progressive MS Archive

Animation der Blutbahn und Immunzellen mit Wirkstoff

Phase 2 Study with Vidofludimus Calcium (IMU838): A Classification

31. March 2023 Prof. Dr. med. Mathias Mäurer General, MS Therapy

Vidofludimus Calcium (IMU838) is a new, selective inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH) from the biotech company Immunic Therapeutics. The manufacturer is currently testing it in patients with relapsing-remitting multiple sclerosis in a phase

High-Dose Biotin is a Dead End

2. July 2021 Prof. Dr. med. Mathias Mäurer Therapy for MS

The treatment options for progressive MS are limited – so interest was high when the study data on the use of high-dose biotin in progressive MS was first presented at the American Neurology Congress in

What is meant by active disease …

14. February 2020 Prof. Dr. med. Mathias Mäurer MS Diagnosis

There is still a lot of confusion regarding the assignment to a specific MS course type. Generally, a distinction is made between relapsing (RMS), secondary chronic progressive (SPMS) and primary chronic progressive (PPMS) multiple sclerosis.

Tag: progressive MS

Phase 2 Study with Vidofludimus Calcium (IMU838): A Classification

High-Dose Biotin is a Dead End

What is meant by active disease …

Thank You!

Recent Posts

Archive

Categories

Links

Follow us

The Expert

The Topics

The Community